There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ligand Pharma
Tag: Joseph Pantginis
Analysts Offer Insights on Healthcare Companies: Fortress Biotech (NASDAQ: FBIO) and Aerpio Pharmaceuticals Inc (NASDAQ: ARPO)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fortress Biotech
H.C. Wainwright Keeps Their Buy Rating on Checkpoint Therapeutics Inc (CKPT)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Checkpoint Therapeutics Inc (CKPT – Research Report) today and set
H.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to Recover
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Caladrius Biosciences (CLBS – Research Report) today and set a
H.C. Wainwright Thinks Sophiris Bio’s Stock is Going to Recover
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Sophiris Bio (SPHS – Research Report) today and set a
H.C. Wainwright Keeps a Buy Rating on Aptose Biosciences (APTO)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Aptose Biosciences (APTO – Research
Analysts Offer Insights on Healthcare Companies: Krystal Biotech Inc (NASDAQ: KRYS), Avenue Therapeutics Inc (NASDAQ: ATXI) and Advaxis (NASDAQ: ADXS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Krystal Biotech Inc